TMCPX
Price
$55.84
Change
+$0.32 (+0.58%)
Updated
Oct 17 closing price
Net Assets
5.18B
VIMAX
Price
$358.27
Change
+$0.63 (+0.18%)
Updated
Oct 17 closing price
Net Assets
201.28B
Interact to see
Advertisement

TMCPX vs VIMAX

Header iconTMCPX vs VIMAX Comparison
Open Charts TMCPX vs VIMAXBanner chart's image
Touchstone Mid Cap Y
Price$55.84
Change+$0.32 (+0.58%)
VolumeN/A
Net Assets5.18B
Vanguard Mid Cap Index Admiral
Price$358.27
Change+$0.63 (+0.18%)
VolumeN/A
Net Assets201.28B
TMCPX vs VIMAX Comparison Chart in %
View a ticker or compare two or three
VS
TMCPX vs. VIMAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TMCPX is a StrongBuy and VIMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 201B vs. TMCPX (5.18B). VIMAX pays higher dividends than TMCPX: VIMAX (1.48) vs TMCPX (0.28). TMCPX was incepted earlier than VIMAX: TMCPX (23 years) vs VIMAX (24 years). TMCPX (0.90) is less costly to investors than VIMAX (0.05). TMCPX is a more actively managed with annual turnover of: 18.00 vs. VIMAX (16.00). TMCPX has a lower initial minimum investment than VIMAX: TMCPX (2500) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 7.58 vs. TMCPX (-3.61). VIMAX return over 5 years is better than : 57.32 vs. TMCPX (35.16).
TMCPXVIMAXTMCPX / VIMAX
Total Expense Ratio0.900.051,800%
Annual Report Gross Expense Ratio0.900.051,800%
Fund Existence23 years24 years-
Gain YTD1.1239.70712%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets5.18B201B3%
Annual Yield % from dividends0.281.4819%
Returns for 1 year-3.617.58-48%
Returns for 3 years37.1749.7075%
Returns for 5 years35.1657.3261%
Returns for 10 years136.48140.9397%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVX1.980.02
+1.02%
NOVONIX Limited
CXM7.620.05
+0.66%
Sprinklr
ATIIU10.59N/A
N/A
Archimedes Tech SPAC Partners II Co
ABVC2.92N/A
N/A
ABVC BioPharma
MDGL438.90-3.23
-0.73%
Madrigal Pharmaceuticals